277 related articles for article (PubMed ID: 16202423)
21. Cytotoxicity of normal and activated rat monocytes analyzed by flow cytometry.
Stehling O; Grau V; Steiniger B
Cytometry A; 2003 Dec; 56(2):81-8. PubMed ID: 14608635
[TBL] [Abstract][Full Text] [Related]
22. A novel telomerase-based approach to detect natural cell-mediated cytotoxic activity against tumor cells in vitro.
Faraoni I; Cottarelli A; Giuliani A; Bonmassar L; Rossi L; Bonmassar E
J Immunol Methods; 2005 Oct; 305(2):162-72. PubMed ID: 16165149
[TBL] [Abstract][Full Text] [Related]
23. A novel four-colour flow cytometric assay to determine natural killer cell or T-cell-mediated cellular cytotoxicity against leukaemic cells in peripheral or bone marrow specimens containing greater than 20% of normal cells.
Zimmermann SY; Esser R; Rohrbach E; Klingebiel T; Koehl U
J Immunol Methods; 2005 Jan; 296(1-2):63-76. PubMed ID: 15680151
[TBL] [Abstract][Full Text] [Related]
24. Development of highly sensitive Bicistronic vector based non-radioactive antigen-specific cytotoxicity assay.
Gupta P; Tayal R; Durgapal H; Rath S; Acharya SK; Panda SK
J Immunol Methods; 2009 Sep; 349(1-2):28-37. PubMed ID: 19682994
[TBL] [Abstract][Full Text] [Related]
25. Effect of cyclosporin A on interleukin-15-activated umbilical cord blood natural killer cell function.
Lin SJ; Kuo ML
Cytotherapy; 2008; 10(4):397-405. PubMed ID: 18574772
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of human mast cell-mediated cytotoxicity by DIOC18 target cell labeling in flow cytometry.
Ozdemir O
J Immunol Methods; 2007 Jan; 319(1-2):98-103. PubMed ID: 17188705
[TBL] [Abstract][Full Text] [Related]
27. Natural killer cell cytotoxicity in patients with recurrent herpes infections: diagnostic utility of a flow cytometric assay.
Devlin LA; Haughton DJ; Crockard AD; Edgar JD
J Clin Pathol; 2010 Mar; 63(3):244-8. PubMed ID: 20203224
[TBL] [Abstract][Full Text] [Related]
28. Stable expression of EBV-gp350 on the surface of NC37 cells confers natural killer (NK)-cell susceptibility or resistance, depending on the assay used to assess NK-mediated function.
Sumonwiriya M; Horhthongkham N; Pattanapanyasat K; Ampol S; Sutthent R; Kantakamalakul W
J Virol Methods; 2009 Oct; 161(1):154-60. PubMed ID: 19539652
[TBL] [Abstract][Full Text] [Related]
29. The VITAL assay: a versatile fluorometric technique for assessing CTL- and NKT-mediated cytotoxicity against multiple targets in vitro and in vivo.
Hermans IF; Silk JD; Yang J; Palmowski MJ; Gileadi U; McCarthy C; Salio M; Ronchese F; Cerundolo V
J Immunol Methods; 2004 Feb; 285(1):25-40. PubMed ID: 14871532
[TBL] [Abstract][Full Text] [Related]
30. Potent suppression of natural killer cell response mediated by the ovarian tumor marker CA125.
Patankar MS; Jing Y; Morrison JC; Belisle JA; Lattanzio FA; Deng Y; Wong NK; Morris HR; Dell A; Clark GF
Gynecol Oncol; 2005 Dec; 99(3):704-13. PubMed ID: 16126266
[TBL] [Abstract][Full Text] [Related]
31. Measuring human mast cell-mediated cytotoxicity against human tumour cells: three-colour flow cytometry using monoclonal antibody target staining with annexin V / propidium iodide co-labelling of death.
Ozdemir O
Allergol Immunopathol (Madr); 2011; 39(5):259-66. PubMed ID: 21236549
[TBL] [Abstract][Full Text] [Related]
32. A Novel Method for Assessment of Natural Killer Cell Cytotoxicity Using Image Cytometry.
Somanchi SS; McCulley KJ; Somanchi A; Chan LL; Lee DA
PLoS One; 2015; 10(10):e0141074. PubMed ID: 26492577
[TBL] [Abstract][Full Text] [Related]
33. Activation-induced programmed cell death of nonspecific cytotoxic cells and inhibition by apoptosis regulatory factors.
Bishop GR; Jaso-Friedmann L; Evans DL
Cell Immunol; 2000 Feb; 199(2):126-37. PubMed ID: 10698622
[TBL] [Abstract][Full Text] [Related]
34. Relationship between target cell recognition and temporal fluctuations in intracellular Ca2+ of human NK cells.
Edwards BS; Nolla HA; Hoffman RR
J Immunol; 1989 Aug; 143(3):1058-65. PubMed ID: 2545776
[TBL] [Abstract][Full Text] [Related]
35. Single-colour flow cytometric assay to determine NK cell-mediated cytotoxicity and viability against non-adherent human tumor cells.
Thakur A; Zaman A; Hummel J; Jones K; Hortelano G
Biotechnol Lett; 2012 Mar; 34(3):447-53. PubMed ID: 22187077
[TBL] [Abstract][Full Text] [Related]
36. Comparison between clonogenic and cytotoxic assays for measuring LAK cell activity.
Kluin-Nelemans HC; van der Harst D; van den Burgh JF; van Luxemburg S; Brand A
Int J Cell Cloning; 1989 Jul; 7(4):232-41. PubMed ID: 2768841
[TBL] [Abstract][Full Text] [Related]
37. KHYG-1, a model for the study of enhanced natural killer cell cytotoxicity.
Suck G; Branch DR; Smyth MJ; Miller RG; Vergidis J; Fahim S; Keating A
Exp Hematol; 2005 Oct; 33(10):1160-71. PubMed ID: 16219538
[TBL] [Abstract][Full Text] [Related]
38. [Mechanism of cell-mediated lysis of autologous platelets in chronic idiopathic thrombocytopenic purpura].
Wang L; Zhang F; Zhu YY; Li LZ; Ma DX; Hou M
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3048-51. PubMed ID: 16324405
[TBL] [Abstract][Full Text] [Related]
39. A novel assay for assessment of HIV-specific cytotoxicity by multiparameter flow cytometry.
Godoy-Ramirez K; Mäkitalo B; Thorstensson R; Sandström E; Biberfeld G; Gaines H
Cytometry A; 2005 Dec; 68(2):71-80. PubMed ID: 16228974
[TBL] [Abstract][Full Text] [Related]
40. Development and application of a multiplexable flow cytometry-based assay to quantify cell-mediated cytolysis.
Cao LF; Krymskaya L; Tran V; Mi S; Jensen MC; Blanchard S; Kalos M
Cytometry A; 2010 Jun; 77(6):534-45. PubMed ID: 20229499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
